What Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices requires
This Regulation reinforces the role of the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (Article 1)…
This is a preview. The full record adds the complete summary, 10 workflow steps, 10 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: European Parliament and Council of the European Union · Version: 1.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0123
SHA-256 integrity: f9f911373e9ce9676c67ae1cd27b7eec0b1f2c26aed88ef848ec0185da72010b
Primary Citations — 5 traced to source
- Regulation (EU) 2022/123, Article 3 - Executive Steering Group on Shortages and Safety of Medicinal Products
- Regulation (EU) 2022/123, Article 4 - Monitoring of events and preparedness
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-reinforced-role-ema-medicines-regulation-2022-123.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-reinforced-role-ema-medicines-regulation-2022-123.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-reinforced-role-ema-medicines-regulation-2022-123
- Back to registry: Browse all 10,102 compliance nodes